{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:47:29Z","timestamp":1790034449068,"version":"4.0.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of the Review<\/jats:title>\n                    <jats:p>Diabesity, the coexistence of type 2 diabetes mellitus (T2DM) and obesity, represents one of the major global health challenges. This review aims to synthesize current evidence on personalized medical nutrition therapy (MNT) and structured physical exercise as cornerstones of diabesity management, with a particular focus on very-low-energy ketogenic therapy (VLEKT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Conventional pharmacotherapies improve glycemic control and promote weight reduction but often fail to fully address the multifactorial pathophysiology of diabesity. MNT has demonstrated significant efficacy in improving glycemic regulation, reducing weight, and modulating cardiometabolic risk factors. Among dietary strategies, the Mediterranean diet provides sustainable benefits, while more intensive interventions such as low-energy diets and ketogenic diets can induce rapid and clinically meaningful improvements, with emerging evidence supporting favorable effects on gut microbiota and inflammation. Complementary lifestyle interventions, particularly structured exercise programs combining aerobic and resistance training, further enhance metabolic outcomes and may contribute to T2DM remission in selected patients. Integration of MNT with incretin-based therapies holds promise for optimizing efficacy while preserving nutritional adequacy and functional health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Effective management of diabesity requires a multidisciplinary, precision-based approach. Personalized MNT and structured exercise represent foundational strategies, while pharmacological therapies provide valuable adjuncts. Among available options, VLEKT stands out for its ability to target key mechanisms of diabesity, including insulin resistance, adiposity, and chronic inflammation. Future diabesity care will rely on integrating nutrition, physical exercise, and pharmacotherapy within individualized frameworks to achieve sustained metabolic control and improved quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13679-026-00688-6","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:23:26Z","timestamp":1773282206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Personalized Medical Nutrition Therapy and Physical Exercise: The Future of Diabesity Care"],"prefix":"10.1007","volume":"15","author":[{"given":"Ludovica","family":"Verde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Annunziata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Camajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Tarsitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Muscogiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Barrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"4","key":"688_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4239\/wjd.v14.i4.396","volume":"14","author":"M Michaelidou","year":"2023","unstructured":"Michaelidou M, Pappachan JM, Jeeyavudeen MS. Management of diabesity: current concepts. World J Diabetes. 2023;14(4):396\u2013411.","journal-title":"World J Diabetes"},{"key":"688_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2018.10.004","volume":"66","author":"JM Pappachan","year":"2019","unstructured":"Pappachan JM, Fernandez CJ, Chacko EC. Diabesity and antidiabetic drugs. Mol Aspects Med. 2019;66:3\u201312.","journal-title":"Mol Aspects Med"},{"key":"688_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14060327","author":"G Martemucci","year":"2024","unstructured":"Martemucci G, et al. Comprehensive strategies for metabolic syndrome: how nutrition, dietary polyphenols, physical activity, and lifestyle modifications address diabesity, cardiovascular diseases, and neurodegenerative conditions. Metabolites. 2024. https:\/\/doi.org\/10.3390\/metabo14060327.","journal-title":"Metabolites"},{"key":"688_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-025-01161-5","author":"L Barrea","year":"2025","unstructured":"Barrea L, et al. Medical nutrition therapy for the management of type 2 diabetes mellitus. Nat Rev Endocrinol. 2025. https:\/\/doi.org\/10.1038\/s41574-025-01161-5.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"688_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.pcd.2019.05.001","volume":"13","author":"JM Razaz","year":"2019","unstructured":"Razaz JM, et al. The health effects of medical nutrition therapy by dietitians in patients with diabetes: A systematic review and meta-analysis: Nutrition therapy and diabetes. Prim Care Diabetes. 2019;13(5):399\u2013408.","journal-title":"Prim Care Diabetes"},{"issue":"2","key":"688_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jand.2017.11.021","volume":"118","author":"K Briggs Early","year":"2018","unstructured":"Briggs Early K, Stanley K. Position of the Academy of Nutrition and Dietetics: the role of medical nutrition therapy and registered dietitian nutritionists in the prevention and treatment of prediabetes and type 2 diabetes. J Acad Nutr Diet. 2018;118(2):343\u201353.","journal-title":"J Acad Nutr Diet"},{"issue":"10322","key":"688_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0140-6736(21)01919-X","volume":"399","author":"I Lingvay","year":"2022","unstructured":"Lingvay I, et al. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet. 2022;399(10322):394\u2013405.","journal-title":"Lancet"},{"issue":"3","key":"688_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11154-020-09579-0","volume":"21","author":"R Estruch","year":"2020","unstructured":"Estruch R, Ros E. The role of the Mediterranean diet on weight loss and obesity-related diseases. Rev Endocr Metab Disord. 2020;21(3):315\u201327.","journal-title":"Rev Endocr Metab Disord"},{"key":"688_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26040985","author":"A Nani","year":"2021","unstructured":"Nani A, et al. Antioxidant and anti-inflammatory potential of polyphenols contained in Mediterranean diet in obesity: molecular mechanisms. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26040985.","journal-title":"Molecules"},{"issue":"3","key":"688_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/joim.13333","volume":"290","author":"M Guasch-Ferre","year":"2021","unstructured":"Guasch-Ferre M, Willett WC. The Mediterranean diet and health: a comprehensive overview. J Intern Med. 2021;290(3):549\u201366.","journal-title":"J Intern Med"},{"issue":"6","key":"688_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nu13062086","volume":"13","author":"S Juray","year":"2021","unstructured":"Juray S, Axen KV, Trasino SE. Remission of type 2 diabetes with very low-calorie diets-a narrative review. Nutrients. 2021;13(6):2086.","journal-title":"Nutrients"},{"issue":"1","key":"688_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1573399812666151005123431","volume":"13","author":"L Sellahewa","year":"2017","unstructured":"Sellahewa L, et al. A Systematic Review of Evidence on the Use of Very Low Calorie Diets in People with Diabetes. Curr Diabetes Rev. 2017;13(1):35\u201346.","journal-title":"Curr Diabetes Rev"},{"key":"688_CR13","doi-asserted-by":"crossref","unstructured":"Yancy WS Jr., Mitchell NS, Westman EC. Ketogenic diet for obesity and diabetes. JAMA Intern Med. 2019;179(12):1734\u20135.","DOI":"10.1001\/jamainternmed.2019.5148"},{"issue":"3","key":"688_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/nutrit\/nuab040","volume":"80","author":"M Rafiullah","year":"2022","unstructured":"Rafiullah M, Musambil M, David SK. Effect of a very low-carbohydrate ketogenic diet vs recommended diets in patients with type 2 diabetes: a meta-analysis. Nutr Rev. 2022;80(3):488\u2013502.","journal-title":"Nutr Rev"},{"key":"688_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/nu16234002","author":"M Rondanelli","year":"2024","unstructured":"Rondanelli M, et al. Does the ketogenic diet mediate inflammation markers in obese and overweight adults? A systematic review and meta-analysis of randomized clinical trials. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16234002.","journal-title":"Nutrients"},{"key":"688_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/nu14050981","author":"BY Zang","year":"2022","unstructured":"Zang BY, He LX, Xue L. Intermittent fasting: potential bridge of obesity and diabetes to health? Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14050981.","journal-title":"Nutrients"},{"issue":"9","key":"688_CR17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/jdi.14186","volume":"15","author":"N Sukkriang","year":"2024","unstructured":"Sukkriang N, Buranapin S. Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: a randomized controlled trial. J Diabetes Investig. 2024;15(9):1297\u2013305.","journal-title":"J Diabetes Investig"},{"key":"688_CR18","unstructured":"Chadt, A., et al., Molecular links between Obesity and Diabetes: \"Diabesity\", in Endotext, K.R. Feingold, et al., Editors. 2000: South Dartmouth (MA)."},{"key":"688_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejim.2023.09.002","volume":"117","author":"G Muscogiuri","year":"2023","unstructured":"Muscogiuri G, Verde L, Colao A. Body mass index (BMI): still be used? Eur J Intern Med. 2023;117:50\u20131.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"688_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000497124","volume":"12","author":"G Fruhbeck","year":"2019","unstructured":"Fruhbeck G, et al. The ABCD of obesity: an EASO position statement on a diagnostic term with clinical and scientific implications. Obes Facts. 2019;12(2):131\u20136.","journal-title":"Obes Facts"},{"key":"688_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22.","journal-title":"Front Cardiovasc Med"},{"key":"688_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.804719","volume":"9","author":"R Pujia","year":"2022","unstructured":"Pujia R, et al. Advances in phenotyping obesity and in its dietary and pharmacological treatment: a narrative review. Front Nutr. 2022;9:804719.","journal-title":"Front Nutr"},{"issue":"4","key":"688_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","volume":"6","author":"I Hameed","year":"2015","unstructured":"Hameed I, et al. Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J Diabetes. 2015;6(4):598\u2013612.","journal-title":"World J Diabetes"},{"issue":"5","key":"688_CR24","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1007\/s00210-024-03713-4","volume":"398","author":"R Sindhwani","year":"2025","unstructured":"Sindhwani R, Bora KS, Hazra S. The dual challenge of diabesity: pathophysiology, management, and future directions. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(5):4891\u2013912.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"688_CR25","doi-asserted-by":"publisher","DOI":"10.1530\/EC-25-0521","author":"W Hu","year":"2025","unstructured":"Hu W, Zhu H, Gong F. Leptin and leptin resistance in obesity: current evidence, mechanisms and future directions. Endocr Connect. 2025. https:\/\/doi.org\/10.1530\/EC-25-0521.","journal-title":"Endocr Connect"},{"issue":"5","key":"688_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/joim.13435","volume":"291","author":"P Arner","year":"2022","unstructured":"Arner P, Ryden M. Human white adipose tissue: a highly dynamic metabolic organ. J Intern Med. 2022;291(5):611\u201321.","journal-title":"J Intern Med"},{"issue":"4","key":"688_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473\u201381.","journal-title":"J Clin Invest"},{"issue":"2","key":"688_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.16263","volume":"27","author":"M Bluher","year":"2025","unstructured":"Bluher M. An overview of obesity-related complications: the epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes. Diabetes Obes Metab. 2025;27(2):3\u201319.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"688_CR29","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1210\/jc.2015-2860","volume":"101","author":"F Cinti","year":"2016","unstructured":"Cinti F, et al. Evidence of beta-cell dedifferentiation in human type 2 diabetes. J Clin Endocrinol Metab. 2016;101(3):1044\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"37","key":"688_CR30","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1073\/pnas.1006639107","volume":"107","author":"RH Unger","year":"2010","unstructured":"Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci U S A. 2010;107(37):16009\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16\u201318","key":"688_CR31","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1089\/ars.2023.0524","volume":"40","author":"X Li","year":"2024","unstructured":"Li X, et al. Oxidative stress, endothelial dysfunction, and N-acetylcysteine in type 2 diabetes mellitus. Antioxid Redox Signal. 2024;40(16\u201318):968\u201389.","journal-title":"Antioxid Redox Signal"},{"issue":"20","key":"688_CR32","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.3390\/ijms262010096","volume":"26","author":"E Mlynarska","year":"2025","unstructured":"Mlynarska E, et al. Endothelial Dysfunction as the Common Pathway Linking Obesity, Hypertension and Atherosclerosis. Int J Mol Sci. 2025;26(20):10096.","journal-title":"Int J Mol Sci"},{"key":"688_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133294","author":"M Gliozzi","year":"2019","unstructured":"Gliozzi M, et al. Modulation of nitric oxide synthases by oxidized LDLs: role in vascular inflammation and atherosclerosis development. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20133294.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"688_CR34","doi-asserted-by":"publisher","first-page":"E56","DOI":"10.1002\/oby.20047","volume":"21","author":"S Champaneri","year":"2013","unstructured":"Champaneri S, et al. Diurnal salivary cortisol is associated with body mass index and waist circumference: the multiethnic study of atherosclerosis. Obesity. 2013;21(1):E56-63.","journal-title":"Obesity"},{"issue":"3","key":"688_CR35","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00125-019-05059-6","volume":"63","author":"IC Mason","year":"2020","unstructured":"Mason IC, et al. Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes. Diabetologia. 2020;63(3):462\u201372.","journal-title":"Diabetologia"},{"issue":"6","key":"688_CR36","first-page":"546","volume":"16","author":"VK Sharma","year":"2020","unstructured":"Sharma VK, Singh TG. Chronic stress and diabetes mellitus: interwoven pathologies. Curr Diabetes Rev. 2020;16(6):546\u201356.","journal-title":"Curr Diabetes Rev"},{"issue":"7","key":"688_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081121","volume":"14","author":"RA DeFronzo","year":"2024","unstructured":"DeFronzo RA, et al. Study protocol for a prospective, multicentre study of hypercortisolism in patients with difficult-to-control type 2 diabetes (CATALYST): prevalence and treatment with mifepristone. BMJ Open. 2024;14(7):e081121.","journal-title":"BMJ Open"},{"issue":"7","key":"688_CR38","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1210\/jc.2006-2540","volume":"92","author":"H Bruehl","year":"2007","unstructured":"Bruehl H, et al. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab. 2007;92(7):2439\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"688_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1043-2760(00)00352-0","volume":"12","author":"M Caprio","year":"2001","unstructured":"Caprio M, et al. Leptin in reproduction. Trends Endocrinol Metab. 2001;12(2):65\u201372.","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"688_CR40","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1210\/endo.140.11.7088","volume":"140","author":"M Caprio","year":"1999","unstructured":"Caprio M, et al. Expression of functional leptin receptors in rodent Leydig cells. Endocrinology. 1999;140(11):4939\u201347.","journal-title":"Endocrinology"},{"key":"688_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/789653","volume":"2012","author":"C Mammi","year":"2012","unstructured":"Mammi C, et al. Androgens and adipose tissue in males: a complex and reciprocal interplay. Int J Endocrinol. 2012;2012:789653.","journal-title":"Int J Endocrinol"},{"issue":"8","key":"688_CR42","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/j.1742-1241.2010.02376.x","volume":"64","author":"R Kadiyala","year":"2010","unstructured":"Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract. 2010;64(8):1130\u20139.","journal-title":"Int J Clin Pract"},{"key":"688_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02349","volume":"10","author":"RH Song","year":"2019","unstructured":"Song RH, et al. The impact of obesity on thyroid autoimmunity and dysfunction: a systematic review and meta-analysis. Front Immunol. 2019;10:2349.","journal-title":"Front Immunol"},{"issue":"2","key":"688_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(19)30345-6","volume":"8","author":"EP Thong","year":"2020","unstructured":"Thong EP, et al. Diabetes: a metabolic and reproductive disorder in women. The Lancet Diabetes & Endocrinology. 2020;8(2):134\u201349.","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"9","key":"688_CR45","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1210\/jc.2010-2724","volume":"96","author":"P Dandona","year":"2011","unstructured":"Dandona P, Dhindsa S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab. 2011;96(9):2643\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"688_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/dme.13977","volume":"37","author":"EJ Gianatti","year":"2020","unstructured":"Gianatti EJ, Grossmann M. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment. Diabet Med. 2020;37(2):174\u201386.","journal-title":"Diabet Med"},{"issue":"10","key":"688_CR47","first-page":"3673","volume":"84","author":"AM Isidori","year":"1999","unstructured":"Isidori AM. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab. 1999;84(10):3673\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/nu11092185","author":"M Infante","year":"2019","unstructured":"Infante M, et al. Influence of vitamin D on islet autoimmunity and beta-cell function in type 1 diabetes. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11092185.","journal-title":"Nutrients"},{"issue":"3","key":"688_CR49","doi-asserted-by":"publisher","first-page":"355","DOI":"10.7326\/M22-3018","volume":"176","author":"AG Pittas","year":"2023","unstructured":"Pittas AG, et al. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes\u202f: A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Ann Intern Med. 2023;176(3):355\u201363.","journal-title":"Ann Intern Med"},{"key":"688_CR50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/978-3-319-55330-6_25","volume":"982","author":"A Gonzalez-Franquesa","year":"2017","unstructured":"Gonzalez-Franquesa A, Patti ME. Insulin resistance and mitochondrial dysfunction. Adv Exp Med Biol. 2017;982:465\u2013520.","journal-title":"Adv Exp Med Biol"},{"key":"688_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/nu16010034","author":"E Pavlidou","year":"2023","unstructured":"Pavlidou E, et al. Diabesity and dietary interventions: evaluating the impact of Mediterranean diet and other types of diets on obesity and type 2 diabetes management. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu16010034.","journal-title":"Nutrients"},{"issue":"3","key":"688_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11154-020-09580-7","volume":"21","author":"FF Casanueva","year":"2020","unstructured":"Casanueva FF, et al. Ketogenic diets as treatment of obesity and type 2 diabetes mellitus. Rev Endocr Metab Disord. 2020;21(3):381\u201397.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"688_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11154-019-09514-y","volume":"21","author":"M Castellana","year":"2020","unstructured":"Castellana M, et al. Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis. Rev Endocr Metab Disord. 2020;21(1):5\u201316.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"688_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15010022","volume":"15","author":"V Palmas","year":"2025","unstructured":"Palmas V, et al. Impact of ketogenic and Mediterranean diets on gut microbiota profile and clinical outcomes in drug-naive patients with diabesity: a 12-month pilot study. Metabolites. 2025;15(1):22.","journal-title":"Metabolites"},{"issue":"3","key":"688_CR55","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0756","volume":"1","author":"S Carter","year":"2018","unstructured":"Carter S, Clifton PM, Keogh JB. Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: a randomized noninferiority trial. JAMA Netw Open. 2018;1(3):e180756.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"688_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jand.2024.06.222","volume":"125","author":"CK Miller","year":"2025","unstructured":"Miller CK. Medical nutrition therapy: still relevant in the era of pharmacotherapy for obesity care. J Acad Nutr Diet. 2025;125(5):595\u20139.","journal-title":"J Acad Nutr Diet"},{"issue":"1","key":"688_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41387-018-0025-1","volume":"8","author":"HE Billingsley","year":"2018","unstructured":"Billingsley HE, Carbone S. The antioxidant potential of the Mediterranean diet in patients at high cardiovascular risk: an in-depth review of the PREDIMED. Nutr Diabetes. 2018;8(1):13.","journal-title":"Nutr Diabetes"},{"issue":"11","key":"688_CR58","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40618-019-01061-2","volume":"42","author":"M Caprio","year":"2019","unstructured":"Caprio M, et al. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2019;42(11):1365\u201386.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"688_CR59","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000515381","volume":"14","author":"G Muscogiuri","year":"2021","unstructured":"Muscogiuri G, et al. European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis. Obes Facts. 2021;14(2):222\u201345.","journal-title":"Obes Facts"},{"issue":"3","key":"688_CR60","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40618-023-02258-2","volume":"47","author":"L Barrea","year":"2024","unstructured":"Barrea L, et al. Ketogenic nutritional therapy (KeNuT)-a multi-step dietary model with meal replacements for the management of obesity and its related metabolic disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-diet therapies in endocrinology and metabolism. J Endocrinol Invest. 2024;47(3):487\u2013500.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"688_CR61","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s13668-024-00560-w","volume":"13","author":"L Barrea","year":"2024","unstructured":"Barrea L, et al. A new nomenclature for the Very Low-Calorie Ketogenic Diet (VLCKD): Very Low-Energy Ketogenic Therapy (VLEKT). Ketodiets and nutraceuticals expert panels: \u201cKetoNut\u201d, Italian Society of Nutraceuticals (SINut) and the Italian Association of Dietetics and Clinical Nutrition (ADI). Curr Nutr Rep. 2024;13(3):552\u20136.","journal-title":"Curr Nutr Rep"},{"issue":"1","key":"688_CR62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/jhn.12938","volume":"35","author":"A Brown","year":"2022","unstructured":"Brown A, et al. Dietary strategies for remission of type 2 diabetes: a narrative review. J Hum Nutr Diet. 2022;35(1):165\u201378.","journal-title":"J Hum Nutr Diet"},{"issue":"4","key":"688_CR63","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jneb.2012.12.004","volume":"45","author":"BC Wingo","year":"2013","unstructured":"Wingo BC, et al. Self-efficacy as a predictor of weight change and behavior change in the PREMIER trial. J Nutr Educ Behav. 2013;45(4):314\u201321.","journal-title":"J Nutr Educ Behav"},{"issue":"3","key":"688_CR64","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1037\/0033-2909.127.3.325","volume":"127","author":"HA Raynor","year":"2001","unstructured":"Raynor HA, Epstein LH. Dietary variety, energy regulation, and obesity. Psychol Bull. 2001;127(3):325\u201341.","journal-title":"Psychol Bull"},{"key":"688_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-3-9","volume":"3","author":"AH Manninen","year":"2006","unstructured":"Manninen AH. Very-low-carbohydrate diets and preservation of muscle mass. Nutr Metab Lond. 2006;3:9.","journal-title":"Nutr Metab Lond"},{"key":"688_CR66","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa336","author":"S Basciani","year":"2020","unstructured":"Basciani S, et al. Very-low-calorie ketogenic diets with whey, vegetable, or animal protein in patients with obesity: a randomized pilot study. J Clin Endocrinol Metab. 2020. https:\/\/doi.org\/10.1210\/clinem\/dgaa336.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"688_CR67","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1017\/S0007114521002609","volume":"127","author":"D Ashtary-Larky","year":"2022","unstructured":"Ashtary-Larky D, et al. Ketogenic diets, physical activity and body composition: a review. Br J Nutr. 2022;127(12):1898\u2013920.","journal-title":"Br J Nutr"},{"issue":"6","key":"688_CR68","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/nu17060965","volume":"17","author":"D Dynka","year":"2025","unstructured":"Dynka D, et al. Ketogenic Diets for Body Weight Loss: A Comparison with Other Diets. Nutrients. 2025;17(6):965.","journal-title":"Nutrients"},{"key":"688_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/nu17030422","author":"G Annunziata","year":"2025","unstructured":"Annunziata G, et al. Very Low Energy Ketogenic Therapy (VLEKT), not only a price matter: a comparison study on average costs of VLEKT with fresh foods and replacement meals. Nutrients. 2025. https:\/\/doi.org\/10.3390\/nu17030422.","journal-title":"Nutrients"},{"key":"688_CR70","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2147\/DMSO.S278928","volume":"14","author":"N Kapoor","year":"2021","unstructured":"Kapoor N, et al. Consensus on Medical Nutrition Therapy for Diabesity (CoMeND) in Adults: A South Asian Perspective. Diabetes Metab Syndr Obes. 2021;14:1703\u201328.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"10","key":"688_CR71","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046252","volume":"11","author":"X Zhao","year":"2021","unstructured":"Zhao X, et al. Effectiveness of combined exercise in people with type 2 diabetes and concurrent overweight\/obesity: a systematic review and meta-analysis. BMJ Open. 2021;11(10):e046252.","journal-title":"BMJ Open"},{"issue":"6","key":"688_CR72","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.3390\/cimb46060327","volume":"46","author":"P Malkowska","year":"2024","unstructured":"Malkowska P. Positive effects of physical activity on insulin signaling. Curr Issues Mol Biol. 2024;46(6):5467\u201387.","journal-title":"Curr Issues Mol Biol"},{"issue":"4","key":"688_CR73","doi-asserted-by":"publisher","first-page":"e13273","DOI":"10.1111\/obr.13273","volume":"22","author":"JM Oppert","year":"2021","unstructured":"Oppert JM, et al. Exercise training in the management of overweight and obesity in adults: Synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group. Obes Rev. 2021;22(4):e13273.","journal-title":"Obes Rev"},{"issue":"8","key":"688_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110365","volume":"27","author":"FM Ribeiro","year":"2024","unstructured":"Ribeiro FM, et al. Discontinuation of HIIT restores diabesity while retraining increases gut microbiota diversity. iScience. 2024;27(8):110365.","journal-title":"iScience"},{"issue":"3","key":"688_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.artere.2025.500754","volume":"37","author":"AA Lopez-Gonzalez","year":"2025","unstructured":"Lopez-Gonzalez AA, et al. Association between sociodemographic variables, healthy habits and stress with diabesity. Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis (English Edition). 2025;37(3):500754.","journal-title":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis (English Edition)"},{"issue":"8","key":"688_CR76","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jcjd.2022.10.005","volume":"46","author":"S Jin","year":"2022","unstructured":"Jin S, et al. Remission of type 2 diabetes: user\u2019s guide: Diabetes Canada Clinical Practice Guidelines Expert Working Group. Can J Diabetes. 2022;46(8):762\u201374.","journal-title":"Can J Diabetes"},{"issue":"10","key":"688_CR77","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/dom.13802","volume":"21","author":"M Ried-Larsen","year":"2019","unstructured":"Ried-Larsen M, et al. Type 2 diabetes remission 1 year after an intensive lifestyle intervention: a secondary analysis of a randomized clinical trial. Diabetes Obes Metab. 2019;21(10):2257\u201366.","journal-title":"Diabetes Obes Metab"},{"key":"688_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/jfmk5030070","author":"F Cannata","year":"2020","unstructured":"Cannata F, et al. Beneficial effects of physical activity in diabetic patients. J Funct Morphol Kinesiol. 2020. https:\/\/doi.org\/10.3390\/jfmk5030070.","journal-title":"J Funct Morphol Kinesiol"},{"issue":"5","key":"688_CR79","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/acr.24179","volume":"73","author":"X Jiang","year":"2021","unstructured":"Jiang X, et al. Precision medicine approach to develop and internally validate optimal exercise and weight-loss treatments for overweight and obese adults with knee osteoarthritis: data from a single-center randomized trial. Arthritis Care Res (Hoboken). 2021;73(5):693\u2013701.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"688_CR80","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1002\/j.2040-4603.2022.tb00211.x","volume":"12","author":"KM Lavin","year":"2022","unstructured":"Lavin KM, et al. State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions. Compr Physiol. 2022;12(2):3193\u2013279.","journal-title":"Compr Physiol"},{"issue":"5","key":"688_CR81","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1152\/japplphysiol.00973.2010","volume":"110","author":"C Bouchard","year":"2011","unstructured":"Bouchard C, et al. Genomic predictors of the maximal O(2) uptake response to standardized exercise training programs. J Appl Physiol. 2011;110(5):1160\u201370.","journal-title":"J Appl Physiol"},{"issue":"6","key":"688_CR82","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1152\/japplphysiol.01295.2009","volume":"108","author":"JA Timmons","year":"2010","unstructured":"Timmons JA, et al. Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985). 2010;108(6):1487\u201396.","journal-title":"J Appl Physiol (1985)"},{"issue":"9702","key":"688_CR83","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","volume":"374","author":"Diabetes Prevention Program Research G","year":"2009","unstructured":"Diabetes Prevention Program Research G, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677\u201386.","journal-title":"Lancet"},{"issue":"6","key":"688_CR84","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393\u2013403.","journal-title":"N Engl J Med"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00688-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-026-00688-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00688-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:47:05Z","timestamp":1773290825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-026-00688-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1007\/s13679-026-00688-6","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"20"}}